Flu is the most common infectious disease that millions of people worldwide get infected each year. While most of them recover within a week, an unfortunate lose their life to the seasonal flu virus.
Abu Dhabi-based G42 Healthcare has announced a volunteer healthcare management programme with Boston-based wearable technology firm WHOOP. The partnership will offer volunteers participating in the world’s first Phase III trials of an COVID-19 vaccine the opportunity to benefit from a 24/7 fitness and health monitor to measure key biometrics. This is the first trial of its kind to feature wearable technology and will include thousands of volunteers who are participating in the trials.
According to news on June 29 from Middle East News Agency, Favipiravir, the popular drug used for treating COVID-19 has shown excellent results in clinical tests. AP, Fox and Deutsche Presse-Agentur have also reported the important role of Favipiravir in the successful fight against the virus in China.